Press release
Non-Alcoholic Steatohepatitis (NASH) Market: Accelerating Growth, Market Size, and Key Trends Outlook to 2029
Non-Alcoholic Steatohepatitis (NASH) Market Share
Trends, Growth Drivers, and Key Market Statistics of Non-Alcoholic Steatohepatitis (NASH)
What Is The Projected Market Size Of The Global Non-Alcoholic Steatohepatitis (NASH) Market And Its Growth Rate?
The Non-Alcoholic Steatohepatitis (NASH) Market is experiencing rapid growth due to increasing prevalence of NASH-related diseases and advancements in drug development. Key market stats include:
•2024 Market Size: $4.5 billion
•2025 Market Size: $6.13 billion (36.1% CAGR)
•2029 Market Size: $19.07 billion (32.8% CAGR)
This growth hinges on rising prevalence of NASH, obesity epidemic, healthcare infrastructure development, and increasing NASH screening initiatives.
What Is Driving The Growth In The Non-Alcoholic Steatohepatitis (NASH) Market?
The growth of the Non-Alcoholic Steatohepatitis (NASH) Market is largely driven by the rise in cases of obesity. An escalating obesity epidemic has led to an increase in non-alcoholic fatty liver disease prevalence, ultimately driving the need for NASH treatment and related drugs. For instance, the World Health Organization reported in March 2024 that approximately 2.5 billion adults were overweight in 2022, with 890 million living with obesity. These rising rates of obesity will continue to fuel the growth of the NASH market.
Request A Free Sample Copy from https://www.thebusinessresearchcompany.com/sample.aspx?id=8805&type=smp
Who Are the Key Players Driving Non-Alcoholic Steatohepatitis (NASH) Market Growth?
Major companies propelling the growth of the NASH market include:
•NGM Biopharmaceuticals Inc.
•Novartis AG
•AstraZeneca plc.
•GlaxoSmithKline plc.
•F. Hoffmann-La Roche AG
•The Takeda Pharmaceutical Company Limited
•Gilead Sciences Inc.
•Novo Nordisk A/S
•Genfit SA
•Cadila Pharmaceuticals Ltd.
What Are The Key Trends In The Non-Alcoholic Steatohepatitis (NASH) Market?
Key market trends include:
•Focus on lifestyle interventions and patient education
•Increased collaboration in clinical research
•Regulatory advancements and pathway designations
•Integration of artificial intelligence in diagnosis and monitoring
What Are The Segments Of The Global Non-Alcoholic Steatohepatitis (NASH) Market?
The market is segmented into the following:
1) By Type: Solid, Liquid
2) By Product: Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib and Cenicriviroc, Other Products
3) By Disease Cause: Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity
4) By Sales Channel: Hospital Pharmacy, Retail Pharmacy, Online Provider
5) By Application: Oral, Parenteral
Which Region Leads The Non-Alcoholic Steatohepatitis (NASH) Market?
North America held the largest market share for Non-Alcoholic Steatohepatitis (NASH) in 2024. Other regions covered in the report include Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, and Africa.
Pre-Book the Report for Swift Delivery from https://www.thebusinessresearchcompany.com/report/non-alcoholic-steatohepatitis-nash-global-market-report
What Is Covered In The Non-Alcoholic Steatohepatitis (NASH) Market Global Market Report?
Market Size Analysis: Analyze the Non-Alcoholic Steatohepatitis (NASH) Market size by key regions, countries, product types, and applications.
Market Segmentation Analysis: Identify various subsegments within the Non-Alcoholic Steatohepatitis (NASH) Market for effective categorization.
Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
Market Contribution: Evaluate contributions of different segments to the overall Non-Alcoholic Steatohepatitis (NASH) Market growth.
Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
Industry Challenges: Analyze challenges and risks affecting the Non-Alcoholic Steatohepatitis (NASH) Market.
Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report from https://www.thebusinessresearchcompany.com/customise?id=8805&type=smp
Learn More About The Business Research Company
The Business Research Company, with over 15,000+ reports from 27 industries across 60+ geographies, provides comprehensive, data-rich research and insights to help businesses stay ahead. Our Global Market Model (GMM) is a premier market intelligence platform delivering real-time forecasts.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Alcoholic Steatohepatitis (NASH) Market: Accelerating Growth, Market Size, and Key Trends Outlook to 2029 here
News-ID: 3844370 • Views: …
More Releases from The Business research company
Foam Tape Industry to Achieve $14.62 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Foam Tape Market Grow by 2025 in Terms of Size and Growth?
In recent times, there has been significant growth in the market size for foam tape. It is projected to escalate from $10.02 billion in 2024 to $10.77 billion in 2025, demonstrating a compound annual growth rate (CAGR)…
Continuous Positive Airway Pressure (CPAP) Mask Market Expansion Outlook: $3.85 …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Projected CAGR for the Continuous Positive Airway Pressure (CPAP) Mask Market from 2024 to 2025?
In recent times, the market size of the continuous positive airway pressure (cpap) mask has seen robust growth. The market is projected to rise from $2.83 billion in 2024 to $3 billion in 2025,…
Alkyd Coating Market to Record 7.5% CAGR Growth Through 2029 | Global Analysis R …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Alkyd Coating Market Outlook: How is the Market Expected to Grow by 2025?
The market size of alkyd coatings has experienced significant growth in the past few years. The market is projected to expand from $25.13 billion in 2024 to $26.74 billion in 2025, exhibiting a compound annual growth rate…
Water Free Skincare Market Analysis: $22.5 Billion by 2029 With a CAGR of 7%
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
Water Free Skincare Market Value Projection: How Much Will the Market Size by 2025?
The market size of waterless skincare has experienced a robust increase in recent years. The expected growth is from $15.96 billion in 2024 to $17.15 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%.…
More Releases for NASH
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Non-Alcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2023
Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease. It is characterized by the accumulation of fat in the liver, inflammation, and damage. NASH can lead to cirrhosis, liver failure, and death. The exact cause of NASH is unknown, but it is believed to be associated with obesity, insulin resistance, and diabetes. Treatment of NASH is focused on weight loss, exercise, and the control of diabetes and insulin resistance.
NASH…
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028
The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining…
NASH Market Insight and Landscape report
Report Snapshot:
NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their…
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017.
Listening to the Beatles and Jack White growing…
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region
Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will…
